125 related articles for article (PubMed ID: 25658676)
1. Targeting epithelial-to-mesenchymal transition for cancer therapy.
Wang Z
Curr Pharm Des; 2015; 21(10):1239. PubMed ID: 25658676
[No Abstract] [Full Text] [Related]
2. Therapeutic implications of cancer epithelial-mesenchymal transition (EMT).
Cho ES; Kang HE; Kim NH; Yook JI
Arch Pharm Res; 2019 Jan; 42(1):14-24. PubMed ID: 30649699
[TBL] [Abstract][Full Text] [Related]
3. Twist-BRD4 complex: potential drug target for basal-like breast cancer.
Shi J; Cao J; Zhou BP
Curr Pharm Des; 2015; 21(10):1256-61. PubMed ID: 25506891
[TBL] [Abstract][Full Text] [Related]
4. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
Du B; Shim JS
Molecules; 2016 Jul; 21(7):. PubMed ID: 27455225
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-mesenchymal transition: a new target in anticancer drug discovery.
Marcucci F; Stassi G; De Maria R
Nat Rev Drug Discov; 2016 May; 15(5):311-25. PubMed ID: 26822829
[TBL] [Abstract][Full Text] [Related]
6. Improvement of chemosensitivity and inhibition of migration via targeting tumor epithelial-to-mesenchymal transition cells by ADH-1-modified liposomes.
Guo Z; Li W; Yuan Y; Zheng K; Tang Y; Ma K; Cui C; Wang L; He B; Zhang Q
Drug Deliv; 2018 Nov; 25(1):112-121. PubMed ID: 29260912
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-to-Mesenchymal Transition: Liaison between Cancer Metastasis and Drug Resistance.
Du F; Liu H; Lu Y; Zhao X; Fan D
Crit Rev Oncog; 2017; 22(3-4):275-282. PubMed ID: 29604904
[TBL] [Abstract][Full Text] [Related]
8. Roles of Dietary Phytoestrogens on the Regulation of Epithelial-Mesenchymal Transition in Diverse Cancer Metastasis.
Lee GA; Hwang KA; Choi KC
Toxins (Basel); 2016 May; 8(6):. PubMed ID: 27231938
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of epithelial-mesenchymal transition by hypoxia in cancer: targets and therapy.
Wang JQ; Wu KJ
Curr Pharm Des; 2015; 21(10):1272-8. PubMed ID: 25506893
[TBL] [Abstract][Full Text] [Related]
10. Targeting cell migration protein could slow cancer cells spreading.
Parks L
Future Med Chem; 2013 Feb; 5(2):122. PubMed ID: 23476966
[No Abstract] [Full Text] [Related]
11. Simultaneous Fluorescence Visualization of Epithelial-Mesenchymal Transition and Apoptosis Processes in Tumor Cells for Evaluating the Impact of Epithelial-Mesenchymal Transition on Drug Efficacy.
Luan M; Chang J; Pan W; Chen Y; Li N; Tang B
Anal Chem; 2018 Sep; 90(18):10951-10957. PubMed ID: 30152682
[TBL] [Abstract][Full Text] [Related]
12. Advances in cancer therapeutics.
Sparreboom A; Verweij J
Clin Pharmacol Ther; 2009 Feb; 85(2):113-7. PubMed ID: 19151631
[No Abstract] [Full Text] [Related]
13. Recent advances of thermally responsive nanogels for cancer therapy.
Wang Y; Xu H; Ma L
Ther Deliv; 2015; 6(10):1157-69. PubMed ID: 26478174
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronate-Lipid Nanohybrids: Fruitful Harmony in Cancer Targeting.
Freag MS
Curr Pharm Des; 2017; 23(35):5283-5291. PubMed ID: 28552066
[TBL] [Abstract][Full Text] [Related]
15. IGF-IR signaling in epithelial to mesenchymal transition and targeting IGF-IR therapy: overview and new insights.
Li H; Batth IS; Qu X; Xu L; Song N; Wang R; Liu Y
Mol Cancer; 2017 Jan; 16(1):6. PubMed ID: 28137302
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-mesenchymal transition: Initiation by cues from chronic inflammatory tumor microenvironment and termination by anti-inflammatory compounds and specialized pro-resolving lipids.
Lee CH
Biochem Pharmacol; 2018 Dec; 158():261-273. PubMed ID: 30389404
[TBL] [Abstract][Full Text] [Related]
17. Targeting tumors.
Sobel RK
US News World Rep; 2000 Oct; 129(13):48-50. PubMed ID: 11183328
[No Abstract] [Full Text] [Related]
18. Clinical significance of epithelial-mesenchymal transition and cancer stem cells.
Topcul M; Cetin I
J BUON; 2016; 21(2):312-9. PubMed ID: 27273939
[TBL] [Abstract][Full Text] [Related]
19. New targets and innovative strategies in cancer treatment: a short course for clinicians. 7-8 February 2003, Monte Carlo, Monaco.
Eskens F
IDrugs; 2003 Mar; 6(3):207-10. PubMed ID: 12838991
[No Abstract] [Full Text] [Related]
20. Metformin reveals a mitochondrial copper addiction of mesenchymal cancer cells.
Müller S; Versini A; Sindikubwabo F; Belthier G; Niyomchon S; Pannequin J; Grimaud L; Cañeque T; Rodriguez R
PLoS One; 2018; 13(11):e0206764. PubMed ID: 30399175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
